420 related articles for article (PubMed ID: 27256670)
1. Clinical Outcomes of Transplanted Modified Bone Marrow-Derived Mesenchymal Stem Cells in Stroke: A Phase 1/2a Study.
Steinberg GK; Kondziolka D; Wechsler LR; Lunsford LD; Coburn ML; Billigen JB; Kim AS; Johnson JN; Bates D; King B; Case C; McGrogan M; Yankee EW; Schwartz NE
Stroke; 2016 Jul; 47(7):1817-24. PubMed ID: 27256670
[TBL] [Abstract][Full Text] [Related]
2. Two-year safety and clinical outcomes in chronic ischemic stroke patients after implantation of modified bone marrow-derived mesenchymal stem cells (SB623): a phase 1/2a study.
Steinberg GK; Kondziolka D; Wechsler LR; Lunsford LD; Kim AS; Johnson JN; Bates D; Poggio G; Case C; McGrogan M; Yankee EW; Schwartz NE
J Neurosurg; 2018 Nov; 131(5):1462-1472. PubMed ID: 30497166
[TBL] [Abstract][Full Text] [Related]
3. Phase I/II Study of Safety and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells in Chronic Stroke.
Levy ML; Crawford JR; Dib N; Verkh L; Tankovich N; Cramer SC
Stroke; 2019 Oct; 50(10):2835-2841. PubMed ID: 31495331
[TBL] [Abstract][Full Text] [Related]
4. Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial.
Prasad K; Sharma A; Garg A; Mohanty S; Bhatnagar S; Johri S; Singh KK; Nair V; Sarkar RS; Gorthi SP; Hassan KM; Prabhakar S; Marwaha N; Khandelwal N; Misra UK; Kalita J; Nityanand S;
Stroke; 2014 Dec; 45(12):3618-24. PubMed ID: 25378424
[TBL] [Abstract][Full Text] [Related]
5. Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials.
Petrou P; Gothelf Y; Argov Z; Gotkine M; Levy YS; Kassis I; Vaknin-Dembinsky A; Ben-Hur T; Offen D; Abramsky O; Melamed E; Karussis D
JAMA Neurol; 2016 Mar; 73(3):337-44. PubMed ID: 26751635
[TBL] [Abstract][Full Text] [Related]
6. Cell Therapy for Chronic TBI: Interim Analysis of the Randomized Controlled STEMTRA Trial.
Kawabori M; Weintraub AH; Imai H; Zinkevych I; McAllister P; Steinberg GK; Frishberg BM; Yasuhara T; Chen JW; Cramer SC; Achrol AS; Schwartz NE; Suenaga J; Lu DC; Semeniv I; Nakamura H; Kondziolka D; Chida D; Kaneko T; Karasawa Y; Paadre S; Nejadnik B; Bates D; Stonehouse AH; Richardson RM; Okonkwo DO
Neurology; 2021 Feb; 96(8):e1202-e1214. PubMed ID: 33397772
[TBL] [Abstract][Full Text] [Related]
7. A Phase 2 Randomized, Sham-Controlled Trial of Internal Carotid Artery Infusion of Autologous Bone Marrow-Derived ALD-401 Cells in Patients With Recent Stable Ischemic Stroke (RECOVER-Stroke).
Savitz SI; Yavagal D; Rappard G; Likosky W; Rutledge N; Graffagnino C; Alderazi Y; Elder JA; Chen PR; Budzik RF; Tarrel R; Huang DY; Hinson JM
Circulation; 2019 Jan; 139(2):192-205. PubMed ID: 30586746
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): A Phase I Safety Clinical Trial.
Glassberg MK; Minkiewicz J; Toonkel RL; Simonet ES; Rubio GA; DiFede D; Shafazand S; Khan A; Pujol MV; LaRussa VF; Lancaster LH; Rosen GD; Fishman J; Mageto YN; Mendizabal A; Hare JM
Chest; 2017 May; 151(5):971-981. PubMed ID: 27890713
[TBL] [Abstract][Full Text] [Related]
9. Intracerebral transplantation of autologous adipose-derived stem cells for chronic ischemic stroke: A phase I study.
Chiu TL; Baskaran R; Tsai ST; Huang CY; Chuang MH; Syu WS; Harn HJ; Lin YC; Chen CH; Huang PC; Wang YF; Chuang CH; Lin PC; Lin SZ
J Tissue Eng Regen Med; 2022 Jan; 16(1):3-13. PubMed ID: 34644444
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal Injection of Allogenic Bone Marrow-Derived Mesenchymal Stromal Cells in Treatment of Patients with Severe Ischemic Stroke: Study Protocol for a Randomized Controlled Observer-Blinded Trial.
Deng L; Peng Q; Wang H; Pan J; Zhou Y; Pan K; Li J; Wu Y; Wang Y
Transl Stroke Res; 2019 Apr; 10(2):170-177. PubMed ID: 29796934
[TBL] [Abstract][Full Text] [Related]
11. Stem cell therapy: a clinical trial of stroke.
Bhasin A; Srivastava MV; Mohanty S; Bhatia R; Kumaran SS; Bose S
Clin Neurol Neurosurg; 2013 Jul; 115(7):1003-8. PubMed ID: 23183251
[TBL] [Abstract][Full Text] [Related]
12. Autologous Mesenchymal Stem Cells Improve Motor Recovery in Subacute Ischemic Stroke: a Randomized Clinical Trial.
Jaillard A; Hommel M; Moisan A; Zeffiro TA; Favre-Wiki IM; Barbieux-Guillot M; Vadot W; Marcel S; Lamalle L; Grand S; Detante O;
Transl Stroke Res; 2020 Oct; 11(5):910-923. PubMed ID: 32462427
[TBL] [Abstract][Full Text] [Related]
13. Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial.
Kondziolka D; Steinberg GK; Wechsler L; Meltzer CC; Elder E; Gebel J; Decesare S; Jovin T; Zafonte R; Lebowitz J; Flickinger JC; Tong D; Marks MP; Jamieson C; Luu D; Bell-Stephens T; Teraoka J
J Neurosurg; 2005 Jul; 103(1):38-45. PubMed ID: 16121971
[TBL] [Abstract][Full Text] [Related]
14. Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial.
Moniche F; Gonzalez A; Gonzalez-Marcos JR; Carmona M; Piñero P; Espigado I; Garcia-Solis D; Cayuela A; Montaner J; Boada C; Rosell A; Jimenez MD; Mayol A; Gil-Peralta A
Stroke; 2012 Aug; 43(8):2242-4. PubMed ID: 22764211
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Intravenous Mesenchymal Stem Cells for Motor Recovery After Ischemic Stroke: A Neuroimaging Study.
Lee J; Chang WH; Chung JW; Kim SJ; Kim SK; Lee JS; Sohn SI; Kim YH; Bang OY;
Stroke; 2022 Jan; 53(1):20-28. PubMed ID: 34583525
[TBL] [Abstract][Full Text] [Related]
16. Intravenous Allogeneic Mesenchymal Stem Cells for Nonischemic Cardiomyopathy: Safety and Efficacy Results of a Phase II-A Randomized Trial.
Butler J; Epstein SE; Greene SJ; Quyyumi AA; Sikora S; Kim RJ; Anderson AS; Wilcox JE; Tankovich NI; Lipinski MJ; Ko YA; Margulies KB; Cole RT; Skopicki HA; Gheorghiade M
Circ Res; 2017 Jan; 120(2):332-340. PubMed ID: 27856497
[TBL] [Abstract][Full Text] [Related]
17. Intra-arterial bone marrow mononuclear cells (BM-MNCs) transplantation in acute ischemic stroke (IBIS trial): protocol of a phase II, randomized, dose-finding, controlled multicenter trial.
Moniche F; Escudero I; Zapata-Arriaza E; Usero-Ruiz M; Prieto-León M; de la Torre J; Gamero MA; Tamayo JA; Ochoa-Sepúlveda JJ; Maestre J; Carmona M; Piñero P; Calderón-Cabrera C; Jimenez MD; Gonzalez A; Montaner J
Int J Stroke; 2015 Oct; 10(7):1149-52. PubMed ID: 26044701
[TBL] [Abstract][Full Text] [Related]
18. A novel approach to transplanting bone marrow stem cells to repair human myocardial infarction: delivery via a noninfarct-relative artery.
Yang Z; Zhang F; Ma W; Chen B; Zhou F; Xu Z; Zhang Y; Zhang D; Zhu T; Wang L; Wang H; Ding Z; Zhang Y
Cardiovasc Ther; 2010 Dec; 28(6):380-5. PubMed ID: 20337639
[TBL] [Abstract][Full Text] [Related]
19. [Current status of development for regenerative cell therapy, SB623].
Kaneko T
Nihon Yakurigaku Zasshi; 2018; 151(3):117-121. PubMed ID: 29526920
[TBL] [Abstract][Full Text] [Related]
20. Intracerebral transplantation of MRI-trackable autologous bone marrow stromal cells for patients with subacute ischemic stroke.
Kawabori M; Kuroda S; Shichinohe H; Kahata K; Shiratori S; Ikeda S; Harada T; Hirata K; Tha KK; Aragaki M; Terasaka S; Ito YM; Nishimoto N; Ohnishi S; Yabe I; Kudo K; Houkin K; Fujimura M
Med; 2024 May; 5(5):432-444.e4. PubMed ID: 38547868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
